Toggle navigation
About
Approach
Team
Companies
News Room
Contact
Medicxi portfolio company MiroBio to be acquired by Gilead Sciences for approximately $405 million
Press Release
Phathom Pharmaceuticals Announces FDA Approval of VOQUEZNA™ TRIPLE PAK™ (vonoprazan, amoxicillin, clarithromycin) and VOQUEZNA™ DUAL PAK™ (vonoprazan, amoxicillin)
Press Release
Rivus Pharmaceuticals Announces Positive Data from Phase 2a Clinical Trial of Lead Candidate HU6, Demonstrating Fat Reduction and Weight Loss in High BMI Participants
Press Release
Centessa Announces Pricing of Initial Public Offering
Press Release
